Idiopathic pulmonary fibrosis stands as one of medicine’s most challenging respiratory conditions, gradually transforming healthy lung tissue into stiff, scarred material that severely ...

Patients with connective tissue disease-related interstitial lung disease show slower decline in lung function and longer ...

According to data from the Health Insurance Review and Assessment Service in 2023, there are an estimated 15,000 patients ...

Panelists discuss how progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF), though distinct in etiology, share a common trajectory of irreversible lung scarring and ...

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified a previously overlooked protein, ...

Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease characterized by progressive decline in lung function. 1 The pathogenesis of IPF is thought to involve aberrant wound ...

The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry. Respir Res. 2019;20(1):59. doi:10.1186 ...

Pulmonary fibrosis is a rare, ... post-COVID-19-Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis. ... so that may explain the different patterns of pulmonary fibrosis progression.

When breathing becomes increasingly difficult with no clear explanation, idiopathic pulmonary fibrosis (IPF) might be the culprit behind the concerning symptoms. This rare yet devastating lung ...

Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J ...